BLOG

Can NK Cell Therapy Be Combined With Standard Cancer Treatment?

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you or a family member is receiving cancer treatment, it is natural to wonder whether an additional option such as NK cell therapy could be used at the same time. Many patients worry that adding something new might interfere with the treatment their oncologist has recommended. This article explains how combination is generally thought about, what is and is not known, and which questions are worth raising before you decide. It is general information, not medical advice for your situation.

The short answer: it depends on your situation and your doctors

Standard cancer treatment, such as surgery, chemotherapy, and radiation therapy, remains the foundation of care for most people. NK cell therapy at Grand Green Osaka Umekita Clinic is described as a treatment that can be used alongside these standard treatments rather than replacing them. Whether it makes sense for you, and when, is a decision that needs a physician’s examination, your medical records, and ideally a conversation with the doctor who is managing your standard treatment.

No one can promise a particular outcome from any cancer treatment. Combination should be seen as an option to discuss, not as a way to improve results with certainty.

What NK cell therapy involves, in brief

Natural killer (NK) cells are a type of lymphocyte in the innate immune system. They can recognize and attack abnormal cells, including some cancer cells and virus-infected cells, without waiting for instructions from other immune cells. Research suggests that NK cell activity can be reduced by aging, stress, and the effects of cancer and its treatment.

In NK cell therapy, cells are collected from your own blood through a standard blood draw. They are then activated and expanded at a specialized cell processing facility and returned to you by intravenous infusion. Because the cells come from you, this is called an autologous approach. The treatment does not require hospitalization, so many people can continue daily life while receiving it, although this should be confirmed for your own case.

How combination with surgery, chemotherapy, and radiation is usually considered

The clinic’s information states that the therapy does not interfere with surgery, chemotherapy, or radiation therapy, and can therefore be used together with them. In practice, the details matter. Several points are typically discussed between the treating doctors and the patient.

  • Timing: the blood draw and infusion schedule may need to be arranged around chemotherapy cycles, radiation sessions, or recovery after surgery.
  • Blood counts and general condition: chemotherapy can lower blood cell counts and affect how you feel, which may influence when cells can be collected or infused.
  • Current medications: your oncologist needs to know about every treatment you are receiving, including any immunotherapy drugs.
  • Your overall goals: some people are in active treatment, while others have finished treatment and are considering follow-up options.

Published studies of NK cell and other immune cell approaches vary widely in cancer type, design, and results. A single study should not be read as proof that a combination works for everyone, and evidence for any given cancer type may be limited. It is reasonable to ask your doctor what is known and what is still uncertain.

Why coordination with your oncologist matters

Your oncologist knows your diagnosis, stage, treatment plan, and test results. That knowledge is essential for deciding whether any additional treatment fits safely into your plan. Grand Green Osaka Umekita Clinic says it can coordinate with the medical institution providing your standard treatment, which can help keep everyone informed.

If you are traveling to Osaka from another country, coordination takes extra planning. It may help to bring or send recent records, such as diagnosis summaries, imaging reports, blood test results, and a list of current medications, ideally in English or with a translation. Telling your home oncologist about your plans early avoids surprises and lets them raise concerns in advance.

Please do not stop, delay, or change your standard treatment because of information on a website. Any change to that treatment should be decided together with the doctor who prescribed it.

Understanding the possible effects, costs, and legal framework

NK cell therapy is a self-pay (non-insured) treatment in Japan, meaning it is not covered by national health insurance. It is offered under Japan’s Act on the Safety of Regenerative Medicine, which requires a provision plan to be submitted to and accepted by the government. This framework is about how treatment is managed, and it does not by itself tell you whether a therapy will help you.

Because the therapy uses your own cells, the risk of rejection is considered low, and serious side effects have rarely been reported. Even so, temporary fever or fatigue may occur, and other effects are possible. Costs, the number of sessions, risks, and side effects should all be confirmed in a medical consultation before you agree to anything. Ask for these details in writing, including what is and is not included in the quoted fees.

Questions to bring to your consultation

A short list of questions can make a first consultation more productive. You may want to ask both your oncologist and the clinic in Osaka.

  • Is there any reason, based on my current treatment, that NK cell therapy should wait or should not be considered?
  • How would the schedule be arranged around my chemotherapy, radiation, or surgery?
  • What is known about this approach for my type and stage of cancer, and what is uncertain?
  • Who will share information between my treating doctors, and in what language?
  • What are the total costs, the expected number of sessions, and the possible risks and side effects?
  • What follow-up will be arranged, and how will I be supported after I return home?

Summary and next steps

NK cell therapy is described as an option that may be used alongside surgery, chemotherapy, and radiation, not instead of them. Whether it is appropriate depends on your diagnosis, your current treatment, and your physician’s assessment. The most useful first step is to talk with your oncologist, then arrange a consultation with Grand Green Osaka Umekita Clinic in Umeda, Osaka, where an information page for international patients is also available. Come prepared with your records and questions, and take the time you need to decide.

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact